OMNICEF 300 mg a (Omnicef 300 mg)
Generic Name: cefdinir
Pill imprint OMNICEF 300 mg a has been identified as Omnicef 300 mg.
Omnicef is used in the treatment of sinusitis; skin or soft tissue infection; strep throat; otitis media; skin and structure infection (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Omnicef 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- cefdinir
- Imprint:
- OMNICEF 300 mg a
- Strength:
- 300 mg
- Color:
- Purple / Green
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-3769
More about Omnicef (cefdinir)
Consumer resources
- Other brands: Omnicef Omni-Pac
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
